Myeloid Poldip2 Contributes to the Development of Pulmonary Inflammation by Regulating Neutrophil Adhesion in a

Ziwei Ou1,2, Elena Dolmatova1, Rohan Mandavilli1

  • 1Division of Cardiology Department of Medicine Emory University Atlanta GA.

Insights

Myeloid Poldip2 regulates neutrophil recruitment in lung injury by controlling beta-2 integrin activation. This finding is crucial for understanding acute respiratory distress syndrome and developing targeted therapies.

Area of Science:

  • Immunology
  • Cell Biology
  • Pulmonary Medicine

Background:

  • Acute respiratory distress syndrome (ARDS) involves lung injury driven by excessive neutrophil recruitment.
  • Polymerase delta-interacting protein 2 (Poldip2) influences endothelial permeability and leukocyte recruitment.
  • Myeloid Poldip2's role in neutrophil recruitment to inflamed lungs was investigated.

Purpose of the Study:

  • To investigate the role of myeloid Poldip2 in neutrophil recruitment during lipopolysaccharide-induced lung injury.
  • To elucidate the mechanisms by which Poldip2 affects neutrophil-endothelial interactions.

Main Methods:

  • Characterization of myeloid-specific Poldip2 knockout mice.
  • Analysis of bronchoalveolar lavage fluid for inflammatory cell counts.
  • In vitro assessment of neutrophil functions including adherence and transmigration.
  • Examination of beta-2 integrin surface expression, binding, and Pyk2 phosphorylation.

Main Results:

  • Myeloid Poldip2 deficiency reduced inflammatory cell and neutrophil accumulation in LPS-induced lung injury.
  • Poldip2-deficient neutrophils showed impaired adherence and transmigration across TNF-α-stimulated endothelial cells.
  • Beta-2 integrin activation and Pyk2 phosphorylation were reduced in Poldip2-deficient neutrophils.
  • Neutrophil extracellular trap formation, ROS production, and cytokine induction were unaffected by Poldip2 deficiency in vitro.

Conclusions:

  • Myeloid Poldip2 is essential for regulating beta-2 integrin activation in neutrophils.
  • Poldip2-mediated beta-2 integrin activation is critical for neutrophil adhesion to endothelium in ARDS.
  • Targeting myeloid Poldip2 may offer a therapeutic strategy for ARDS.